DaVita Inc.

NYSE DVA

DaVita Inc. Price to Earnings Ratio (P/E) on January 14, 2025: 16.05

DaVita Inc. Price to Earnings Ratio (P/E) is 16.05 on January 14, 2025, a 32.98% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.
  • DaVita Inc. 52-week high Price to Earnings Ratio (P/E) is 16.95 on October 16, 2024, which is 5.60% above the current Price to Earnings Ratio (P/E).
  • DaVita Inc. 52-week low Price to Earnings Ratio (P/E) is 11.97 on January 23, 2024, which is -25.47% below the current Price to Earnings Ratio (P/E).
  • DaVita Inc. average Price to Earnings Ratio (P/E) for the last 52 weeks is 14.81.
Key data
Date Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield
Market news
Loading...
NYSE: DVA

DaVita Inc.

CEO Mr. Javier J. Rodriguez
IPO Date Oct. 31, 1995
Location United States
Headquarters 2000 16th Street
Employees 70,000
Sector Health Care
Industries
Description

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Similar companies

EHC

Encompass Health Corporation

USD 93.06

0.54%

SGRY

Surgery Partners, Inc.

USD 19.85

-6.19%

ENSG

The Ensign Group, Inc.

USD 133.50

0.88%

AMED

Amedisys, Inc.

USD 91.98

0.01%

THC

Tenet Healthcare Corporation

USD 127.63

-1.27%

UHS

Universal Health Services, Inc.

USD 184.16

-0.85%

HCA

HCA Healthcare, Inc.

USD 305.79

-0.78%

OPCH

Option Care Health, Inc.

USD 28.72

3.61%

AMN

AMN Healthcare Services, Inc.

USD 26.12

-5.40%

USPH

U.S. Physical Therapy, Inc.

USD 88.70

-0.64%

ACHC

Acadia Healthcare Company, Inc.

USD 44.37

-2.29%

CYH

Community Health Systems, Inc.

USD 2.91

-3.32%

StockViz Staff

January 15, 2025

Any question? Send us an email